(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Verici Dx PLC shares soared on Thursday after the company secured Medicare coverage in the US for its flagship kidney transplant diagnostic test, Tutivia, marking a "key milestone" in the test's commercial rollout. Read More
(Alliance News) - Stock prices in London opened higher on Thursday, as investors digest the latest developments in US President Donald Trump's trade war with China. Read More
(Alliance News) - Verici Dx PLC on Monday reported strong growth in test orders for its Tutivia diagnostic, ahead of an expected decision on US Medicare coverage. Read More
(Alliance News) - Verici Dx PLC on Friday said it was planning to submit supplemental information to Medicare, in order to support the delayed local coverage determination for its Tutivia test. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Verici Dx PLC - develops advanced clinical diagnostics for organ transplants - Notes that Thermo Fisher Scientific Inc confirms the completion of the transfer and achievement of all transfer-related activities for the pre-transplant prognostic testing technology licensed by Verici to Thermo under an agreement signed in November. The event triggers a milestone payment, Verici highlights. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Verici Dx PLC on Friday celebrated the launch of an interactive patient-focused educational tool, named the Patient Journey, to help kidney transplant patients. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Verici Dx PLC on Wednesday said it raised GBP280,000 via a retail offer of new shares, in addition to the GBP6.2 million raised via a placing last month. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Verici Dx PLC on Wednesday said it had undergone a fundraise to support the development and commercialisation of its range of clinical products. Read More
(Alliance News) - Verici Dx PLC on Monday said that pricing had been finalised for two of its pre- and post-transplant tests, in line with the group's strategy to "develop and commercialise a complementary suite of ground-breaking products". Read More
(Alliance News) - Verici Dx PLC on Monday celebrated the publication of data from its Tutivia trial, which demonstrated the efficacy of the post-transplant test, in the American Journal of Transplantation. Read More
